NERVGEN PHARMA CORP (NGEN.CA) Stock Balance Sheet
TSX-V:NGEN - TSX Venture Exchange - CA64082X2032 - Common Stock - Currency: CAD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 16.93M | 5.60M | 4.11M | |||
| Cash Equivalents | N/A | 22.45M | N/A | N/A | N/A | |||
| Receivables | N/A | 27.00K | 64.00K | 62.60K | 122.50K | |||
| Other Current Assets | N/A | 669.90K | 427.60K | 540.70K | 2.03M | |||
| Total Current Assets | N/A | 23.15M | 17.42M | 6.20M | 6.26M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | 295.30K | 2.70K | 2.00K | N/A | |||
| Intangibles | N/A | 431.40K | 473.20K | 471.40K | 509.60K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | N/A | 726.70K | 475.90K | 473.40K | 509.60K | |||
| TOTAL ASSETS | N/A | 23.88M | 17.90M | 6.68M | 6.77M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 86.30K | N/A | N/A | N/A | |||
| Accrued Expenses | N/A | 892.10K | 451.50K | 420.10K | 249.60K | |||
| Accounts Payable | N/A | 2.00M | 352.50K | 171.80K | 501.90K | |||
| Other Current Liabilities | N/A | 7.24M | 274.10K | 163.30K | 172.40K | |||
| Total Current Liabilities | N/A | 10.22M | 1.08M | 755.10K | 924.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | N/A | 197.20K | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Non-Current Liabilities | N/A | 197.10K | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | N/A | 10.41M | 1.08M | 755.10K | 924.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | N/A | -43.95M | -25.59M | -17.03M | -9.45M | |||
| Common Shares | N/A | 57.41M | 42.40M | 22.95M | 15.29M | |||
| Shares Outstanding | N/A | 58.78M | 46.19M | 35.17M | 29.35M | |||
| Tangible Book Value per Share | N/A | 0.22 | 0.35 | 0.15 | 0.18 | |||
| Total Shareholders' Equity | N/A | 13.46M | 16.82M | 5.92M | 5.84M | |||
| TOTAL LIABILITIES AND EQUITY | N/A | 23.88M | 17.90M | 6.68M | 6.77M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.01 | N/A | N/A | N/A | |||
| Current Ratio | N/A | 2.27 | 16.16 | 8.21 | 6.77 | |||
| Return On Assets (ROA) | N/A | -86.79% | -71.11% | -167.57% | -144.34% | |||
| Return On Equity (ROE) | N/A | -153.94% | -75.67% | -188.95% | -167.18% | |||
All data in CAD , ROIC based on taxRate of 0.28